Dude, this is the safety trial and it's only once per day.ClinicalTrials.gov
clinicaltrials.gov
Kintor Pharmaceutical Announced U.S. FDA Has Greenlighted Phase II Clinical Trial for Pyrilutamide to Treat Androgenetic Alopecia
- Thread starter bekeero
- Start date
- Reaction score
- 647
ClinicalTrials.gov
I think it is 1x a day.
q.d. (qd or QD) is once a day; q.d. stands for "quaque die" (which means, in Latin, once a day). t.i.d. (or tid or TID) is three times a day ; t.i.d. stands for "ter in die" (in Latin, 3 times a day). q.i.d. (or qid or QID) is four times a day; q.i.d. stands for "quater in die" (in Latin, 4 times a day).
Looks like it's just different doses QD.
- Reaction score
- 453
Should I be excited?
Nope , they advance fast in the chinese market , you need it to be approved by the fda which is probbly more slow then the chinese health regulator.
sevenseers
Member
- Reaction score
- 29
wrong doomer. once its on the chinese market you can easily get your hands on it. there will be a massive cottage industry of people exporting it around the world, or you could just fly to china and get it. i'll see the great wall while im at it
- Reaction score
- 647
The drug is getting trials in the US. Phase 2 usa trials are still pending.
That kinda too complicated , for example in israel if its not FDA approved , you need alot of papers to get it in .